Stay updated on OpACIN-neo Optimal Combo Trial
Sign up to get notified when there's something new on the OpACIN-neo Optimal Combo Trial page.

Latest updates to the OpACIN-neo Optimal Combo Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded user-help navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and metadata fields (Last verified, Last known status was). Standardized the Intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' and updated the site's revision footer from v3.5.5 to v3.6.0.SummaryDifference1%

- Check17 days agoChange DetectedThe site revision label in the footer was updated from v3.5.4 to v3.5.5. This reflects a deployment update and does not modify the study details or page content.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.5.4 is now shown on the page, replacing the previous Revision: v3.5.3, indicating a small maintenance update to the page.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision label updated to v3.5.3, replacing the previous v3.5.2. This indicates a new page revision without altering the trial information.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision label updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

- Check81 days agoChange Detected- Added the Nat Med 2026 PRADO-trial publication: Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis (Nat Med, 2026 Mar;32(3):952-963; Epub 2026 Jan 28). - Removed the earlier Nat Med ahead-of-print citation (Nat Med, 2026 Jan 28).SummaryDifference0.0%

Stay in the know with updates to OpACIN-neo Optimal Combo Trial
Enter your email address, and we'll notify you when there's something new on the OpACIN-neo Optimal Combo Trial page.